The global industry was valued at US$ 140.2 Bn in 2022 and is estimated to grow at a CAGR of 9.1% from 2023 to 2031, reaching US$ 303.1 Bn by the end of 2031. The anticancer drugs market is witnessing substantial expansion as the global burden of cancer continues to rise and healthcare systems increasingly prioritize advanced oncology treatments. The growing prevalence of various forms of...

  As we move through 2026, the global fight against cancer has entered a phase of unprecedented acceleration. The Oncology Drugs Market Growth Dynamics are currently defined by a "precision-first" approach, where the traditional boundaries between chemotherapy and immunotherapy are blurring. Market valuation is now surging toward the $210 billion mark, fueled by the rapid clinical...

The global erythropoietin drugs market is poised for steady growth, driven by rising prevalence of chronic diseases and increasing focus on advanced anemia management. Valued at US$ 9.4 Bn in 2023, the market is projected to reach US$ 14.3 Bn by 2034, expanding at a CAGR of 3.8% during the forecast period. Understanding Erythropoietin Drugs Erythropoietin (EPO) drugs, also known as...

"In-Depth Study on Executive Summary Oral HER Pathway Targeted Drugs Market Size and Share CAGR Value The global oral HER pathway targeted drugs market size was valued at USD 6.24 billion in 2025 and is expected to reach USD 15.01 billion by 2033, at a CAGR of 11.60% during the forecast period The Oral HER Pathway Targeted Drugs Market report contains...

Demand Outlook for Executive Summary Hormone-Refractory Oncology Drug Market Market Size and Share CAGR Value The global hormone-refractory oncology drug market size was valued at USD 5.33 billion in 2025 and is expected to reach USD 12.46 billion by 2033, at a CAGR of 11.20% during the forecast period The wide-ranging report deals with the new business challenges and investment...

Executive Summary Peptide-Drug Conjugate Therapeutics Market Market Size and Share Across Top Segments CAGR Value The global peptide-drug conjugate therapeutics market size was valued at USD 1.46 billion in 2025 and is expected to reach USD 7.07 billion by 2033, at a CAGR of 21.80% during the forecast period Analysis and discussion of important industry trends, market size, and market...